Central and autonomic effects following the combined administration of sodium arsenite and 2,3-dimercaptopropanol (BAL).
KOPPANYI
T
T
SPERLING
F
F
D001151:Arsenic / Q000494:pharmacology*; D018053:Arsenites; D001337:Autonomic Agents; D004112:Dimercaprol; D009420:Nervous System / Q000187:drug effects*; D004364:Pharmaceutical Preparations; D012964:Sodium; D017670:Sodium Compounds; D013438:Sulfhydryl Compounds / Q000494:pharmacology*
D018053:Arsenites; D001337:Autonomic Agents; D004364:Pharmaceutical Preparations; D017670:Sodium Compounds; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; C017947:sodium arsenite; D012964:Sodium; D001151:Arsenic
ARSENIC/effects; NERVOUS SYSTEM/effects of drugs; SODIUM/arsenite; SULFHYDRYL COMPOUNDS/effects